Seminars in Hematology
Volume 45, Issue 3 , Pages 150-159 , July 2008

Decision-Making When Data and Inferences Are Not Conclusive: Risk-Benefit and Acceptable Regret Approach

  • Iztok Hozo

      Affiliations

    • Department of Mathematics, Indiana University, Gary, IN.
    • ,
  • Michael J. Schell

      Affiliations

    • Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida, Tampa, FL.
    • ,
  • Benjamin Djulbegovic

      Affiliations

    • Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida, Tampa, FL.
    • Corresponding Author InformationAddress correspondence to Benjamin Djulbegovic, MD, PhD, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida, 12902 Magnolia Dr, Tampa, FL 33612.

References 

  1. Tukey J. Conclusions vs. decisions. Technometrics. 1960;2:423–433
  2. deWaal C. On Pragmatism. Belmont, CA: Wadsworth; 2005;
  3. Edwards W, Miles R, vonWinterfeld D. Advances in Decision Analysis (From Foundations to Applications). New York, NY: Cambridge University Press; 2007;
  4. Bell DE, Raiffa H, Tversky A. Decision Making (Descriptive, Normative, and Prescriptive Interactions). Cambridge, UK: Cambridge University Press; 1988;
  5. Ciampi A, Till JE. Null results in clinical trials: The need for a decision-theory approach. Br J Cancer. 1980;41:618–629
  6. Hastie R, Dawes RM. Rational Choice in an Uncertain World. London, UK: Sage; 2001;
  7. Browner WS, Newman TB. Are all significant p values created equal (The analogy between diagnostic tests and clinical research). JAMA. 1987;257:2459–2463
  8. Dagli A, Morse RM, Dalton C, Owen JA, Hayden GF. Formulating clinical questions during community preceptorships: A first step in utilizing evidence-based medicine. Fam Med. 2003;35:619–621
  9. Djulbegovic B, Desoky AH. Equation and nomogram for calculation of testing and treatment thresholds. Med Decis Making. 1996;16:198–199
  10. Djulbegovic B, Hozo I. At what degree of belief in a research hypothesis is a trial in humans justified?. J Eval Clin Practice. 2002;8:269–276
  11. Djulbegovic B, Hozo I. When should potentially false research findings be considered acceptable?. PLoS Med. 2007;4:e26
  12. Pater JL, Willan AR. Clinical trials as diagnostic tests. Controlled Clin Trials. 1984;5:107–113
  13. Pauker S, Kassirer J. Therapeutic decision making: A cost benefit analysis. N Engl J Med. 1975;293:229–234
  14. Pauker SG, Kassirer J. The threshold approach to clinical decision making. N Engl J Med. 1980;302:1109–1117
  15. Djulbegovic B, Hozo I, Schwartz A, McMasters K. Acceptable regret in medical decision making. Med Hypoth. 1999;53:253–259
  16. Djulbegovic B, Hozo I, Lyman GH. Linking evidence-based medicine therapeutic summary measures to clinical decision analysis. Med Gen Med. 2000;2:E6
  17. Hozo I, Djulbegovic B. Using Internet to calculate clinical action thresholds. Comp Biomed Res. 1999;32:168–185
  18. Hozo I, Djulbegovic B: When is diagnostic testing inappropriate or irrational? Acceptable regret approach. Med Decis Making (in press)
  19. Schwarz L, Lellouch J. Explanatory and pragmatic attitudes in therapeutic trials. J Chron Dis. 1967;20:637–648
  20. Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2:e124
  21. Wacholoder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96:432–442
  22. Goodman SN. Toward evidence-based medical statistics (2: The Bayes factor). Ann Intern Med. 1999;130:1005–1013
  23. Gabbay J, le May A. Evidence based guidelines or collectively constructed “mindlines?” (Ethnographic study of knowledge management in primary care). BMJ. 2004;329:1013-1010
  24. Goodman SN. Toward evidence-based medical statitistics (1: The p value fallacy). Ann Intern Med. 1999;130:995–1004
  25. Sinclair JC, Cook RJ, Guyatt GH, Pauker SG, Cook DJ. When should an effective treatment be used? (Derivation of the threshold number needed to treat and the minimum event rate for treatment). J Clin Epidemiol. 2001;54:253–262
  26. Bell DE. Regret in decision making under uncertainty. Operations Res. 1982;30:961–981
  27. Loomes G, Sugden R. Regret theory: An alternative theory of rational choice. Economic J. 1982;92:805–824
  28. Zeelenberg M, Pieters R. A theory of regret regulation 1.0. J Consumer Psychol. 2007;17:3–18
  29. Zeelenberg M, Pieters R. A theory of regret regulation 1.1. J Consumer Psychol. 2007;17:29–35
  30. Djulbegovic B, Hozo I, Schwartz A, McMasters KM. Acceptable regret in medical decision making. Med Hypoth. 1999;53:253–259
  31. Leventhal L, Huynh C-L. Directional decisions for two-tailed tests: Power, error rates, and sample size. Psychol Methods. 1996;3:278–292
  32. FDA Safety Information and Adverse Event Reporting Program. http://www.fda.gov/medwatch/safety/2007/safety07.htmAranesp; accessed April 2008
  33. Rizzo D, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and at American Society of Hematology. J Clin Oncol. 2002;20:4083–4107
  34. Rodgers GM, Becker SP, Bennett CL, Cella D, Chanan-Khan A, Chesney C, et al. Cancer- and treatment-related anemia. http://www.nccn.org/professionals/physician_gls/PDF/anemia.pdfaccessed April 2008
  35. Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, et al. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update. J Clin Oncol. 2008;26:132–149
  36. https://www.cms.hhs.gov/scripts/ctredirector.dll/.pdf?@_CPR0a0a043a07d1.YE_Qa3N_cvb
  37. Fromer M, Hogan M. ESAs: Further labeling restrictions endorsed, questions about safety remain. Oncol Times. 2007;29:23–25
  38. Cassileth PA, Harrington DP, Appelbaum FR, Lazarus HM, Rowe JM, Paietta E, et al. : Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med. 1998;339:1649–1656
  39. Lowenberg B. Post-remission treatment of acute myelogenous leukemia. N Engl J Med. 1995;332:260–262
  40. Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia (European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups). N Engl J Med. 1995;332:217–223
  41. Cornelissen JJ, van Putten WL, Verdonck LF, Theobald M, Jacky E, Daenen SM, et al. Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: Benefits for whom?. Blood. 2007;109:3658–3666
  42. Senn SJ. Falsificationism and clinical trials. Stat Med. 1991;10:1679–1692
  43. Miles R. The Emergence of Decision Analysis. New York, NY: Cambridge University Press; 2007;
  44. Raiffa H. Decision Analysis: A Personal Account of How It Got Started and Evolved. New York, NY: Cambridge University Press; 2007;
  45. Kahneman D. Maps of bounded rationality: Psychology for behavioral economics. Am Econ Rev. 2003;93:1449–1475
  46. Djulbegovic B, Hozo I, Lyman G. Linking evidence-based medicine therapeutic summary measures to clinical decision analysis. Med Gen Med http://www.medscape.com/Medscape/GeneralMedicine/journal/2000/v02.n01/mgm0113.djul/mgm0113.djul-01.htmlJanuary 13, 2000
  47. Djulbegovic B. Articulating and responding to uncertainties in clinical research. J Med Philosophy. 2007;32:79–98

PII: S0037-1963(08)00065-6

doi: 10.1053/j.seminhematol.2008.04.006

Seminars in Hematology
Volume 45, Issue 3 , Pages 150-159 , July 2008

Article Tools

* Image Usage & Resolution